US5474783A
(en)
*
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5719197A
(en)
*
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
CA2115840A1
(en)
*
|
1991-08-27 |
1993-03-04 |
Tsung-Min Hsu |
Transdermal formulation for administering prazosin
|
US6162456A
(en)
*
|
1992-09-24 |
2000-12-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
DE4319096C1
(de)
*
|
1993-06-08 |
1994-09-08 |
Kuhl Herbert Prof Dr Phil Nat |
Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
|
NZ281334A
(en)
*
|
1994-02-28 |
1997-08-22 |
Teijin Ltd |
Transdermal patch comprising isosorbide dinitrate in a mixture of two different adhesives
|
DE4407742C1
(de)
*
|
1994-03-08 |
1995-06-22 |
Hexal Pharma Gmbh |
Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
|
US5714162A
(en)
*
|
1994-09-16 |
1998-02-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Scopolamine patch
|
IT1278545B1
(it)
*
|
1994-10-13 |
1997-11-24 |
Fime Fab It Motor Elett |
Sistema di fissaggio per l'arresto delle palette metalliche delle ventole di aspirazione centrifughe
|
DE4443888A1
(de)
*
|
1994-12-09 |
1996-06-13 |
Bayer Ag |
Dermal applizierbare Formulierungen von Parasitiziden
|
US5605701A
(en)
*
|
1995-02-17 |
1997-02-25 |
Eli Lilly And Company |
Transdermal formulation
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
US6316022B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Noven Pharmaceuticals, Inc. |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
|
AU703593B2
(en)
*
|
1995-06-07 |
1999-03-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
|
CA2223588C
(en)
*
|
1995-06-07 |
2004-01-06 |
Noven Pharmaceuticals, Inc. |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US5906830A
(en)
*
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
US5730721A
(en)
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
US7094422B2
(en)
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US5725876A
(en)
*
|
1996-05-17 |
1998-03-10 |
Noven Pharmaceuticals Inc., |
Compositions and methods for using low-swell clays in nicotine containing dermal compositions
|
US5837289A
(en)
*
|
1996-07-23 |
1998-11-17 |
Grasela; John C. |
Transdermal delivery of medications using a combination of penetration enhancers
|
DE19635883A1
(de)
*
|
1996-09-04 |
1998-03-05 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
|
US6166081A
(en)
*
|
1997-10-09 |
2000-12-26 |
Kushnir; Moshe |
Methods and apparatus for treatment of Parkinson's disease
|
US6746688B1
(en)
|
1996-10-13 |
2004-06-08 |
Neuroderm Ltd. |
Apparatus for the transdermal treatment of Parkinson's disease
|
IL119417A
(en)
*
|
1996-10-13 |
2003-02-12 |
Moshe Kushnir |
Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease
|
US5879701A
(en)
*
|
1997-02-28 |
1999-03-09 |
Cygnus, Inc. |
Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
|
US5976547A
(en)
*
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US7150881B2
(en)
*
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
GB9714650D0
(en)
*
|
1997-07-11 |
1997-09-17 |
Strakan Ltd |
Block copolymer
|
US6711436B1
(en)
|
1997-08-08 |
2004-03-23 |
Duke University |
Compositions, apparatus and methods for facilitating surgical procedures
|
ATE318595T1
(de)
*
|
1997-08-08 |
2006-03-15 |
Univ Duke |
Zusammensetzungen zur vereinfachung von chirurgischen verfahren
|
DE69819748T2
(de)
*
|
1997-09-12 |
2004-09-30 |
Columbia Laboratories (Bermuda) Ltd. |
Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
|
EP1356806A1
(en)
*
|
1997-09-12 |
2003-10-29 |
Columbia Laboratories (Bermuda) Limited |
A pharmaceutical composition for treating dysmenorrhea and premature labor
|
US5919476A
(en)
*
|
1997-09-29 |
1999-07-06 |
Pmt Corporation |
Reinforced gel sheeting for scar treatment
|
AU747041B2
(en)
|
1997-11-10 |
2002-05-09 |
Strakan International Limited |
Penetration enhancing and irritation reducing systems
|
AU1800099A
(en)
*
|
1997-11-25 |
1999-06-15 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US6210705B1
(en)
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US5900249A
(en)
*
|
1998-02-09 |
1999-05-04 |
Smith; David J. |
Multicomponent pain relief topical medication
|
DE19814257A1
(de)
|
1998-03-31 |
1999-10-07 |
Asta Medica Ag |
Brauseformulierungen
|
US20020188037A1
(en)
*
|
1999-04-15 |
2002-12-12 |
Chudzik Stephen J. |
Method and system for providing bioactive agent release coating
|
ATE466603T1
(de)
*
|
1998-04-27 |
2010-05-15 |
Surmodics Inc |
Bioaktive wirkstoffe freisetzende beschichtungen
|
DE19818955C2
(de)
*
|
1998-04-28 |
2000-06-29 |
Lohmann Therapie Syst Lts |
Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat
|
DE19828273B4
(de)
|
1998-06-25 |
2005-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
DE19828274C2
(de)
*
|
1998-06-25 |
2002-11-28 |
Rottapharm Bv |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
DE19830648A1
(de)
*
|
1998-07-09 |
2000-01-13 |
Lohmann Therapie Syst Lts |
Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
|
DE19830649C2
(de)
|
1998-07-09 |
2003-04-10 |
Lohmann Therapie Syst Lts |
Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
|
DE19834496B4
(de)
|
1998-07-31 |
2004-02-26 |
Beiersdorf Ag |
Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
|
CA2341220A1
(en)
|
1998-08-20 |
2000-03-02 |
3M Innovative Properties Company |
Spray on bandage and drug delivery system
|
EP1137406B2
(en)
*
|
1998-12-07 |
2008-01-23 |
J. Dev Limited |
Transdermal patch for delivering volatile liquid drugs
|
US20030170195A1
(en)
*
|
2000-01-10 |
2003-09-11 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for drug delivery
|
DE60017831T3
(de)
*
|
1999-01-14 |
2009-12-17 |
Noven Pharmaceuticals, Inc., Miami |
Dermale zusammensetzungen
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
US6337086B1
(en)
|
1999-02-06 |
2002-01-08 |
Dow Corning Corporation |
Pressure sensitive adhesive compositions for transdermal drug delivery devices
|
DE19908787A1
(de)
*
|
1999-03-01 |
2000-09-14 |
Labtec Gmbh |
Transdermale Applikation von ß2-Sympathomimetika zur Behandlung obstruktiver Atemwegserkrankungen
|
JP2002541094A
(ja)
*
|
1999-04-01 |
2002-12-03 |
アルザ・コーポレーション |
ポリウレタン薬物貯蔵部を含んでなる経皮薬物送達装置
|
DE19918105C1
(de)
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
US7063859B1
(en)
|
1999-04-28 |
2006-06-20 |
Noven Pharmaceuticals, Inc. |
Barrier film lined backing layer composition and method for topical administration of active agents
|
FR2793689B1
(fr)
*
|
1999-05-19 |
2001-08-24 |
Pf Medicament |
Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
|
US6962691B1
(en)
|
1999-05-20 |
2005-11-08 |
U & I Pharmaceuticals Ltd. |
Topical spray compositions
|
AU5325000A
(en)
|
1999-06-05 |
2000-12-28 |
David Houze |
Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
|
US6503950B1
(en)
|
1999-08-23 |
2003-01-07 |
David M. Ockert |
Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
|
US6264973B1
(en)
|
1999-08-26 |
2001-07-24 |
Fei Enterprises, Ltd. |
Apparatus and method for anesthetizing the cervical region of a female
|
WO2001026648A1
(fr)
*
|
1999-10-13 |
2001-04-19 |
Senju Pharmaceutical Co., Ltd. |
Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee
|
ATE287711T1
(de)
*
|
1999-11-29 |
2005-02-15 |
Novosis Ag |
Transdermalsystem zur abgabe von clonidin
|
US6974588B1
(en)
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
US6558695B2
(en)
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
US6562369B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
US6562370B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
US6645520B2
(en)
|
1999-12-16 |
2003-11-11 |
Dermatrends, Inc. |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
US6582724B2
(en)
*
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
US6673363B2
(en)
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
US6562368B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
US6586000B2
(en)
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
US6602912B2
(en)
|
2000-06-30 |
2003-08-05 |
Dermatrends, Inc. |
Transdermal administration of phenylpropanolamine
|
US20020004065A1
(en)
|
2000-01-20 |
2002-01-10 |
David Kanios |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
WO2001064149A1
(en)
*
|
2000-02-29 |
2001-09-07 |
Jie Zhang |
Improved transdermal drug patch
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
DE10012908B4
(de)
*
|
2000-03-16 |
2005-03-17 |
Lts Lohmann Therapie-Systeme Ag |
Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
|
KR100452972B1
(ko)
*
|
2000-05-16 |
2004-10-14 |
주식회사 삼양사 |
경피투여용 하이드로젤 조성물
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
GB0015617D0
(en)
*
|
2000-06-26 |
2000-08-16 |
Vectura Ltd |
Improved preparations for dermal delivery of active substances
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
DE60123960T2
(de)
|
2000-07-14 |
2007-04-26 |
Transform Pharmaceuticals, Inc., Lexington |
System und verfahren zum optimieren des gewebebarrieretransfers von verbindungen
|
US6852526B2
(en)
*
|
2000-07-14 |
2005-02-08 |
Transform Pharmaceuticals, Inc. |
Transdermal assay with magnetic clamp
|
US20080182293A1
(en)
*
|
2000-07-14 |
2008-07-31 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput transdermal experimental processing and digital analysis of comparative samples
|
US7172859B2
(en)
*
|
2000-07-14 |
2007-02-06 |
Transform Pharmaceuticals, Inc. |
System and method for optimizing tissue barrier transfer of compounds
|
JP2004509222A
(ja)
*
|
2000-09-19 |
2004-03-25 |
ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション |
経皮薬物送達システムにおいて有用な非反応型接着剤
|
US20020119187A1
(en)
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
US20020198215A1
(en)
*
|
2000-10-23 |
2002-12-26 |
Lino Tavares |
Terazosin transdermal device and methods
|
EP1340496A4
(en)
*
|
2000-11-07 |
2004-04-14 |
Hisamitsu Pharmaceutical Co |
PHARMACEUTICAL PREPARATION OF THE PERCUTANEOUS ABSORPTION TYPE
|
US20020106402A1
(en)
*
|
2000-12-05 |
2002-08-08 |
Hartwig Rod Lawson |
Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
|
EP1216699A1
(de)
*
|
2000-12-21 |
2002-06-26 |
Schering Aktiengesellschaft |
Transdermalsystem enthaltend ein hochpotentes Gestagen
|
ES2559666T3
(es)
*
|
2001-03-07 |
2016-02-15 |
Hisamitsu Pharmaceutical Co., Inc. |
Parche adhesivo
|
EP1757280A1
(en)
|
2001-03-16 |
2007-02-28 |
ALZA Corporation |
Transdermal patch for administering sufentanyl
|
WO2002074286A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Alza Corporation |
Transdermal patch for administering fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
DE10118282A1
(de)
*
|
2001-04-12 |
2002-12-05 |
Lohmann Therapie Syst Lts |
Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
ATE438418T1
(de)
|
2001-05-01 |
2009-08-15 |
Av Topchiev Inst Petrochemical |
Hydrogel-zusammensetzungen
|
RU2286801C2
(ru)
|
2001-05-01 |
2006-11-10 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Двухфазные биоадгезионные композиции, абсорбирующие воду
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US20030027833A1
(en)
*
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
EP1256339B1
(en)
*
|
2001-05-08 |
2003-10-15 |
Schwarz Pharma Ag |
Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
|
JP5506126B2
(ja)
|
2001-06-18 |
2014-05-28 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
経皮システムにおける加速した医薬の送達
|
NZ531789A
(en)
*
|
2001-08-17 |
2006-01-27 |
Lavipharm Lab Inc |
A medical device from which analgesic drugs are delivered from a drug reservoir controlled by plasticizers and adhesive matrix material
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US6805878B2
(en)
*
|
2001-09-13 |
2004-10-19 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of ACE inhibitors
|
WO2003022270A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of an enalapril ester
|
US8425892B2
(en)
|
2001-10-29 |
2013-04-23 |
Columbia Laboratories, Inc. |
Extended, controlled-release pharmaceutical compositions using charged polymers
|
US20030147972A1
(en)
*
|
2002-02-05 |
2003-08-07 |
Christopher W. Denver |
Method and composition for diminishing loss of color in flavors and fragrances
|
DK1482948T3
(da)
*
|
2002-03-11 |
2006-11-27 |
Janssen Pharmaceutica Nv |
Kontinuerlig sulfataseinhiberende progestogen-hormonsubstitutionsbehandling
|
US20030219471A1
(en)
*
|
2002-03-11 |
2003-11-27 |
Caubel Patrick Michel |
Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
|
US20030225047A1
(en)
*
|
2002-03-11 |
2003-12-04 |
Caubel Patrick Michel |
Sulfatase inhibiting progestogen-only contraceptive regimens
|
CA2496454A1
(en)
|
2002-04-23 |
2003-11-06 |
Alza Corporation |
Transdermal analgesic systems with reduced abuse potential
|
DE10220230A1
(de)
*
|
2002-05-06 |
2003-11-27 |
Sanol Arznei Schwarz Gmbh |
Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
DE10223835A1
(de)
*
|
2002-05-28 |
2003-12-11 |
Labtec Gmbh |
Pflaster, enthaltend Fentanylum
|
WO2003101433A1
(de)
*
|
2002-05-28 |
2003-12-11 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend fentanylum
|
US20030232087A1
(en)
*
|
2002-06-18 |
2003-12-18 |
Lawin Laurie R. |
Bioactive agent release coating with aromatic poly(meth)acrylates
|
US7097850B2
(en)
*
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
KR100983802B1
(ko)
*
|
2002-06-20 |
2010-09-27 |
아스션 더마톨로지 에이/에스 |
폴리히드록시알칸의 지방산 에스테르 및 피리미딘카르복시 유도체의 신규한 복합체
|
NZ537360A
(en)
|
2002-06-25 |
2006-09-29 |
Acrux Dds Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
US20040127978A1
(en)
*
|
2002-08-13 |
2004-07-01 |
Medtronic, Inc. |
Active agent delivery system including a hydrophilic polymer, medical device, and method
|
AU2003258230A1
(en)
*
|
2002-08-13 |
2004-02-25 |
Medtronic, Inc |
Medical device exhibiting improved adhesion between polymeric coating and substrate
|
EP1536846A1
(en)
*
|
2002-08-13 |
2005-06-08 |
Medtronic, Inc. |
Active agent delivery system including a polyurethane, medical device, and method
|
CA2495172A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
EP1530469B1
(en)
*
|
2002-08-20 |
2009-02-25 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and free-base form of an antagonist
|
AU2003268376A1
(en)
*
|
2002-08-30 |
2004-11-26 |
Watson Pharmaceuticals, Inc. |
Transdermal delivery systems and methods
|
CN1700934B
(zh)
*
|
2002-09-06 |
2011-08-03 |
菲利普莫里斯美国公司 |
液体气溶胶制剂和用于制备气溶胶的气溶胶产生装置及方法
|
US7241456B2
(en)
*
|
2002-10-25 |
2007-07-10 |
Australian Importers Ltd. |
Formulations for topical delivery of bioactive substances and methods for their use
|
US6908760B2
(en)
*
|
2002-10-28 |
2005-06-21 |
Transform Pharmaceuticals, Inc. |
Raised surface assay plate
|
US7449307B2
(en)
*
|
2002-10-28 |
2008-11-11 |
Transform Pharmaceuticals, Inc. |
Raised surface assay plate
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
CA2810477C
(en)
|
2002-12-13 |
2013-09-17 |
Durect Corporation |
Oral drug delivery system
|
US20040147534A1
(en)
*
|
2003-01-23 |
2004-07-29 |
Foote Mary Ann |
Topical composition and method for treating occlusive wounds
|
JP4363866B2
(ja)
*
|
2003-03-14 |
2009-11-11 |
リンテック株式会社 |
皮膚貼付材用シリコーン粘着剤組成物及びこれを用いた皮膚貼付材
|
GB0308734D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
US20040208917A1
(en)
*
|
2003-04-16 |
2004-10-21 |
Wilfried Fischer |
Transdermal systems for the release of clonidine
|
WO2004096151A2
(en)
*
|
2003-04-29 |
2004-11-11 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
US20040219195A1
(en)
*
|
2003-04-30 |
2004-11-04 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
KR101159828B1
(ko)
|
2003-04-30 |
2012-07-04 |
퍼듀 퍼머 엘피 |
활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
|
US7182955B2
(en)
*
|
2003-04-30 |
2007-02-27 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US20040237400A1
(en)
*
|
2003-05-27 |
2004-12-02 |
Weder Donald E. |
Plant package with floral wrapper with decorative portion
|
US7576226B2
(en)
*
|
2003-06-30 |
2009-08-18 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process of making isomers of norelgestromin and methods using the same
|
WO2005009417A1
(en)
*
|
2003-07-21 |
2005-02-03 |
Noven Pharmaceuticals, Inc. |
Composition and method for controlling grug delivery from silicone adhesive blends
|
JP2007502281A
(ja)
*
|
2003-08-13 |
2007-02-08 |
メドトロニック・インコーポレーテッド |
混和性ポリマー配合物を含む活性剤放出系、医療機器、及び方法
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
US8784874B2
(en)
*
|
2003-09-10 |
2014-07-22 |
Noven Pharmaceuticals, Inc. |
Multi-layer transdermal drug delivery device
|
US8586080B1
(en)
*
|
2003-10-28 |
2013-11-19 |
Noven Pharmaceuticals, Inc. |
Inhibiting crystallization of steroidal hormones in transdermal delivery systems
|
AU2004285505B2
(en)
*
|
2003-10-28 |
2010-12-23 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device
|
US20050095279A1
(en)
|
2003-10-30 |
2005-05-05 |
Gale Robert M. |
Transdermal analgesic systems having reduced abuse potential
|
CA2554649C
(en)
|
2004-01-30 |
2015-10-27 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
US9205062B2
(en)
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20050202073A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
AU2011203203B2
(en)
*
|
2004-03-09 |
2014-04-10 |
Mylan Technologies, Inc |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
WO2005097228A2
(en)
|
2004-04-06 |
2005-10-20 |
Surmodics, Inc. |
Coating compositions for bioactive agents
|
US20060083772A1
(en)
*
|
2004-04-06 |
2006-04-20 |
Dewitt David M |
Coating compositions for bioactive agents
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
WO2006017807A2
(en)
|
2004-08-05 |
2006-02-16 |
Corium International, Inc. |
Adhesive composition
|
KR20070053267A
(ko)
*
|
2004-08-20 |
2007-05-23 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
반투명 보호 필름을 갖는 경피 약물 전달 장치
|
TW200616589A
(en)
*
|
2004-10-08 |
2006-06-01 |
Noven Pharma |
Transdermal delivery of drugs based on crystal size
|
CA2583340C
(en)
|
2004-10-08 |
2015-09-08 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device including an occlusive backing
|
WO2006041907A2
(en)
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of estradiol
|
US20060078602A1
(en)
|
2004-10-08 |
2006-04-13 |
Noven Pharmaceuticals, Inc. |
Device for transdermal administration of drugs including acrylic polymers
|
US8252320B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
ATE551995T1
(de)
|
2004-10-21 |
2012-04-15 |
Durect Corp |
Transdermale abgabesysteme
|
WO2006063021A2
(en)
|
2004-12-07 |
2006-06-15 |
Surmodics, Inc. |
Coatngs with crystallized active agents (s)
|
KR100810947B1
(ko)
|
2005-01-28 |
2008-03-10 |
롬 앤드 하아스 컴패니 |
에멀젼 폴리머로부터 제조된 의료용 필름 및 제품
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
ITMI20050477A1
(it)
|
2005-03-23 |
2006-09-24 |
Bouty S P A |
Cerotto transdermico
|
GB0506139D0
(en)
*
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
US20060281775A1
(en)
|
2005-06-14 |
2006-12-14 |
Applied Pharmacy Services, Inc. |
Two-component pharmaceutical composition for the treatment of pain
|
WO2007035941A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal galantamine delivery system
|
EP2308480B1
(en)
|
2005-09-23 |
2014-08-13 |
ALZA Corporation |
High Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
|
US9056061B2
(en)
*
|
2005-09-23 |
2015-06-16 |
Alza Corporation |
Transdermal nicotine salt delivery system
|
US20090130188A9
(en)
|
2005-09-29 |
2009-05-21 |
National Starch And Chemical Investment Holding Company |
Acrylic pressure sensitive adhesives
|
EP1774964B1
(en)
|
2005-10-13 |
2014-08-06 |
Nitto Denko Corporation |
Nicotine transdermal preparation and production method thereof
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
EP1940368A2
(en)
*
|
2005-10-25 |
2008-07-09 |
Dow Corning Corporation |
Transdermal drug delivery system with acrylate or methacrylate functional pressure sensitive adhesive composition
|
KR20070059758A
(ko)
*
|
2005-12-07 |
2007-06-12 |
에스케이케미칼주식회사 |
비스테로이드성 항염증제와 국소마취제를 포함하는 경피투여 조성물
|
US9393218B2
(en)
*
|
2005-12-23 |
2016-07-19 |
Epinamics Gmbh |
Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
|
WO2007097428A1
(ja)
*
|
2006-02-23 |
2007-08-30 |
Mitsubishi Rayon Co., Ltd. |
(メタ)アクリル系重合体粒子、その製造方法、プラスチゾル及び物品
|
AU2007221117A1
(en)
*
|
2006-02-27 |
2007-09-07 |
Noven Pharmaceuticals, Inc. |
Transdermal therapeutic system comprising scopolamine
|
US20070225425A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Nash Paul L |
Low tack elastomer composition, part and methods
|
DE102006019293A1
(de)
*
|
2006-04-21 |
2007-10-25 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend ein Fentanyl Analogum
|
US8124689B2
(en)
*
|
2006-06-06 |
2012-02-28 |
Dow Corning Corporation |
Silicone acrylate hybride composition and method of making same
|
US8614278B2
(en)
|
2006-06-06 |
2013-12-24 |
Dow Corning Corporation |
Silicone acrylate hybrid composition and method of making same
|
US8569416B2
(en)
|
2006-06-06 |
2013-10-29 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
CA2657435A1
(en)
|
2006-07-10 |
2008-07-03 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
US8647664B2
(en)
|
2006-07-14 |
2014-02-11 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive preparation
|
EP2089007A2
(en)
*
|
2006-10-27 |
2009-08-19 |
Noven Pharmaceuticals, INC. |
Transdermal delivery of ketoprofen polar derivatives
|
ES2388355T3
(es)
|
2006-11-03 |
2012-10-11 |
Durect Corporation |
Sistemas de suministro transdémico que comprenden bupivacaína
|
DE102006054732B4
(de)
*
|
2006-11-21 |
2010-12-30 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
|
KR101495577B1
(ko)
*
|
2007-01-11 |
2015-02-25 |
드로싸팜 아게 |
의학적으로 유효한 경고제
|
CN101589105B
(zh)
*
|
2007-01-23 |
2014-08-27 |
三菱丽阳株式会社 |
(甲基)丙烯酸系聚合物粒子、其制造方法、使用(甲基)丙烯酸系聚合物粒子的增塑溶胶组合物以及使用其的物品
|
US20080188446A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Warner Chilcott Company Inc. |
Tetracycline compositions for topical administration
|
CN101147739B
(zh)
*
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
|
CN101801321B
(zh)
*
|
2007-07-10 |
2014-07-02 |
敏捷治疗公司 |
原位密封的经皮输送装置
|
JP5358574B2
(ja)
*
|
2007-08-17 |
2013-12-04 |
アルション セラピューティクス, インコーポレイテッド |
高濃度の局所麻酔薬調合物
|
US20090258061A1
(en)
*
|
2007-10-15 |
2009-10-15 |
Johnson & Johnson |
Once-a-day replacement transdermal administration of fentanyl
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
WO2009073734A2
(en)
*
|
2007-12-03 |
2009-06-11 |
Medipacs, Inc. |
Fluid metering device
|
EP3326621A1
(en)
|
2007-12-06 |
2018-05-30 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
EP2259780A2
(en)
*
|
2008-02-28 |
2010-12-15 |
Syntropharma Limited |
Pharmaceutical composition comprising naltrexone
|
US8231906B2
(en)
|
2008-07-10 |
2012-07-31 |
Noven Pharmaceuticals, Inc. |
Transdermal estrogen device and delivery
|
CN102137908B
(zh)
*
|
2008-07-28 |
2013-10-30 |
陶氏康宁公司 |
复合制品
|
US8119694B2
(en)
*
|
2008-08-15 |
2012-02-21 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations
|
RU2497679C2
(ru)
|
2008-10-02 |
2013-11-10 |
Милан Инк. |
Способ получения многослойного клеящегося ламинированного материала
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
JP5681883B2
(ja)
*
|
2009-03-27 |
2015-03-11 |
株式会社 メドレックス |
核酸を有効成分とする外用剤組成物
|
CN102803420B
(zh)
|
2009-04-24 |
2015-06-03 |
汉高知识产权控股有限责任公司 |
基于硅氧烷丙烯酸杂化聚合物的粘合剂
|
US8299079B2
(en)
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
US9795617B2
(en)
|
2009-06-18 |
2017-10-24 |
Baucom Institute for Longevity and Life Enhancement, Inc. |
Hormone delivery system and method
|
US8658628B2
(en)
*
|
2009-06-18 |
2014-02-25 |
Karan Y. Baucom |
Hormone delivery system and method
|
US20110037455A1
(en)
*
|
2009-08-17 |
2011-02-17 |
Oren Navot |
System for measuring electrical power
|
CH701769A1
(de)
|
2009-09-08 |
2011-03-15 |
Schoeller Textil Ag |
Wiederbeladbare Ausrüstungen für Textilien und Formulierungen zur Beladung solcher Ausrüstungen.
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
EP2506838A1
(en)
*
|
2009-12-01 |
2012-10-10 |
Noven Pharmaceuticals, INC. |
Transdermal testosterone device and delivery
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
CN103491778B
(zh)
|
2010-04-13 |
2017-05-31 |
雷尔玛达治疗股份有限公司 |
1‑甲基‑n‑(2,6‑二甲苯基)‑2‑哌啶甲酰胺的皮肤用药物组合物及其使用方法
|
KR101644349B1
(ko)
|
2010-04-23 |
2016-08-01 |
헨켈 아이피 앤드 홀딩 게엠베하 |
실리콘-아크릴 공중합체
|
WO2012018403A1
(en)
|
2010-08-05 |
2012-02-09 |
Biofilm Ip, Llc |
Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
US9017305B2
(en)
|
2010-11-12 |
2015-04-28 |
The Procter Gamble Company |
Elastomeric compositions that resist force loss and disintegration
|
US20120123369A1
(en)
*
|
2010-11-12 |
2012-05-17 |
David Harry Melik |
Elastomeric compositions that resist force loss and disintegration
|
US10905652B2
(en)
|
2011-03-23 |
2021-02-02 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US8927010B2
(en)
|
2011-03-23 |
2015-01-06 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US9283214B2
(en)
|
2011-03-23 |
2016-03-15 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US10292937B2
(en)
|
2011-03-23 |
2019-05-21 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
US9498447B2
(en)
|
2011-03-23 |
2016-11-22 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US11241391B2
(en)
|
2011-03-23 |
2022-02-08 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
ES2883589T3
(es)
|
2011-03-23 |
2021-12-09 |
Ironshore Pharmaceuticals & Dev Inc |
Procedimientos y composiciones para el tratamiento del trastorno de déficit de atención
|
US9603809B2
(en)
|
2011-03-23 |
2017-03-28 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
US9119809B2
(en)
|
2011-03-23 |
2015-09-01 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US8916588B2
(en)
|
2011-03-23 |
2014-12-23 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods for treatment of attention deficit hyperactivity disorder
|
DE102011114411A1
(de)
*
|
2011-09-26 |
2013-03-28 |
Lts Lohmann Therapie-Systeme Ag |
Pflaster mit einstellbarer Okklusion
|
EP2584016A1
(en)
|
2011-10-21 |
2013-04-24 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
MX365818B
(es)
|
2011-11-23 |
2019-05-30 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo hormonal de combinacion naturales.
|
JP2013139554A
(ja)
|
2011-11-29 |
2013-07-18 |
Dow Corning Corp |
シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
|
EP2847249A4
(en)
|
2012-03-14 |
2016-12-28 |
Medipacs Inc |
SMART POLYMER MATERIALS WITH EXCESSIVE REACTIVE MOLECULES
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US9717697B2
(en)
|
2012-10-15 |
2017-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for the transdermal delivery of methylphenidate
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
JP6550337B2
(ja)
*
|
2012-12-28 |
2019-07-24 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
非ステロイド系の抗炎症薬を経皮的に送達するための組成物及び方法
|
US9314470B2
(en)
|
2012-12-28 |
2016-04-19 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
|
US9295726B2
(en)
|
2012-12-28 |
2016-03-29 |
Noven Pharamceuticals, Inc. |
Multi-polymer compositions for transdermal drug delivery
|
CA2893632A1
(en)
*
|
2013-01-02 |
2014-07-10 |
Kci Licensing, Inc. |
A medical drape having an ultra-thin drape film and a thick adhesive coating
|
WO2014130846A1
(en)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Transdermal drug delivery using amphiphilic dendron-coil micelles
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
AU2014233453A1
(en)
|
2013-03-15 |
2015-10-01 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
ES2694662T3
(es)
|
2013-07-03 |
2018-12-26 |
Lts Lohmann Therapie-Systeme Ag |
Sistema terapéutico transdérmico con componente electrónico
|
EP3144328B1
(en)
*
|
2014-05-12 |
2019-03-06 |
Mitsubishi Chemical Corporation |
Acrylic polymer, method for producing same, and plastisol composition including said acrylic polymer
|
CN106456567A
(zh)
|
2014-05-20 |
2017-02-22 |
Lts勒曼治疗系统股份公司 |
在经皮递送系统中调节活性剂释放的方法
|
EP3145504B1
(en)
|
2014-05-20 |
2023-07-26 |
LTS Lohmann Therapie-Systeme AG |
Transdermal delivery system including an interface mediator
|
CN106456566B
(zh)
|
2014-05-20 |
2020-06-16 |
Lts勒曼治疗系统股份公司 |
含罗替戈汀的经皮递送系统
|
JP5816881B2
(ja)
*
|
2014-05-21 |
2015-11-18 |
株式会社 メドレックス |
核酸を有効成分とする外用剤組成物
|
US10206932B2
(en)
|
2014-05-22 |
2019-02-19 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2016009279A2
(en)
|
2014-06-10 |
2016-01-21 |
Sabic Global Technologies B.V. |
Insecticide-containing coating composition and method for protecting palm trees from pests
|
US10071090B2
(en)
|
2014-07-18 |
2018-09-11 |
Buzzz Pharmaceuticals Limited |
Oxymorphone transdermal patch
|
CA2951284A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
CA2956596A1
(en)
*
|
2014-07-31 |
2016-02-04 |
Noven Pharmaceuticals, Inc. |
Silicone-containing acrylic polymers for transdermal drug delivery compositions
|
WO2016042413A1
(en)
|
2014-09-18 |
2016-03-24 |
Neuroderm, Ltd. |
Opipramol patch
|
US10010543B1
(en)
|
2014-12-23 |
2018-07-03 |
Barr Laboratories, Inc. |
Transdermal dosage form
|
KR101990782B1
(ko)
|
2015-01-29 |
2019-06-19 |
다우 실리콘즈 코포레이션 |
실리콘 아크릴레이트 조성물 및 이의 제조 방법
|
US10406116B2
(en)
|
2015-02-06 |
2019-09-10 |
Noven Pharmaceuticals, Inc. |
Pressure-sensitive adhesives for transdermal drug delivery
|
MX371044B
(es)
|
2015-02-06 |
2020-01-13 |
Noven Pharma |
Adhesivos sensibles a la presión para suministro transdérmico de fármaco.
|
CA2978438A1
(en)
*
|
2015-03-04 |
2016-09-09 |
Noven Pharmaceuticals, Inc. |
Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems
|
JP6526475B2
(ja)
*
|
2015-04-30 |
2019-06-05 |
サンスター株式会社 |
経皮唾液腺投与用の唾液分泌促進剤
|
MX2017014768A
(es)
*
|
2015-05-18 |
2018-03-23 |
Agile Therapeutics Inc |
Composiciones anticonceptivas y metodos para mejorar la eficacia y modulacion de los efectos secundarios.
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017034027A1
(ja)
*
|
2015-08-27 |
2017-03-02 |
東洋インキScホールディングス株式会社 |
貼付剤
|
EP3349737A4
(en)
*
|
2015-09-14 |
2019-05-15 |
Amneal Pharmaceuticals LLC |
SYSTEM FOR TRANSDERING
|
CN108601749A
(zh)
|
2016-02-05 |
2018-09-28 |
3M创新有限公司 |
具有氟代硅氧烷剥离衬件的透皮药物递送体系
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017223402A1
(en)
*
|
2016-06-23 |
2017-12-28 |
Corium International, Inc. |
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
|
AU2017384392B2
(en)
|
2016-12-20 |
2023-05-25 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
|
RU2762896C2
(ru)
|
2016-12-20 |
2021-12-23 |
Лтс Ломанн Терапи-Систем Аг |
Трансдермальная терапевтическая система, содержащая азенапин
|
CN110799180A
(zh)
|
2017-06-26 |
2020-02-14 |
罗曼治疗系统股份公司 |
含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
|
WO2019186300A1
(en)
|
2018-03-28 |
2019-10-03 |
Sabic Global Technologies B.V. |
Peelable adhesive protective film to protect palm trees from the attack of red palm weevil pest
|
CN111936593B
(zh)
|
2018-04-05 |
2022-08-02 |
3M创新有限公司 |
包含聚二有机硅氧烷和丙烯酸类聚合物的交联共混物的凝胶粘合剂
|
CN112704672A
(zh)
|
2018-06-20 |
2021-04-27 |
罗曼治疗系统股份公司 |
含有阿塞那平的透皮治疗系统
|
WO2020008370A1
(en)
|
2018-07-02 |
2020-01-09 |
Clexio Biosciences Ltd. |
Transdermal patch
|
WO2020008366A1
(en)
|
2018-07-02 |
2020-01-09 |
Clexio Biosciences Ltd. |
Transdermal dosage form
|
WO2020009685A1
(en)
|
2018-07-02 |
2020-01-09 |
John Tang |
Transdermal dosage form
|
US20210212958A1
(en)
*
|
2018-07-12 |
2021-07-15 |
Sekisui Chemical Co., Ltd. |
Adhesive composition and adhesive patch
|
CN112206222A
(zh)
*
|
2018-11-09 |
2021-01-12 |
北京德默高科医药技术有限公司 |
含有布洛芬结构类似物的多层经皮给药系统
|
JP6912122B2
(ja)
*
|
2019-02-28 |
2021-07-28 |
日本臓器製薬株式会社 |
経皮投与製剤
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|